You’d Be Wrong to Paint Bionano Genomics Stock With the Meme-Stock Brush

With Bionano’s disruptive tool, Saphyr, poised to revolutionize the DNA analysis sector, investors should definitely look to buy BNGO stock on its recent dip. Read More